{
    "root": "886776e4-26b1-4f8f-9817-69288536f783",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Auvi-Q",
    "value": "20250414",
    "ingredients": [
        {
            "name": "EPINEPHRINE",
            "code": "YKH834O4BH",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00668"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_26710"
        },
        {
            "name": "SODIUM BISULFITE",
            "code": "TZX5469Z6I",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14015"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        }
    ],
    "indications": {
        "text": "auvi-q indicated emergency treatment type allergic , including anaphylaxis , adult pediatric patients weigh 7.5 kg greater .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "recommended auvi-q based weight . ( 2.1 ) administer auvi-q intramuscularly subcutaneously anterolateral aspect thigh , clothing necessary . ( 2.2 ) recommended patient \u2019 weight 30 kg greater auvi-q 0.3 mg 15 kg less 30 kg auvi-q 0.15 mg 7.5 kg less 15 kg auvi-q 0.1 mg absence improvement symptoms worsen initial treatment , second dose auvi-q may administered second autoinjector starting 5 minutes first dose . ( 2.1 ) advise patients seek emergency medical assistance close monitoring anaphylactic episode event treatment required . ( 2.1 ) recommended patients prescribed immediate access two auvi-q devices times . ( 2.1 ) full prescribing information instructions . ( 2.2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "supplied auvi-q ( epinephrine injection ) clear colorless solution intramuscular subcutaneous . auvi-q available autoinjector described table 2. table 2. auvi-q autoinjector package configurations strengths package configuration strength national code ( ndc ) 2 autoinjectors 0.3 mg/0.3 ml ndc 60842-023-02 2 autoinjectors 0.15 mg/0.15 ml ndc 60842-022-02 2 autoinjectors 0.1 mg/0.1 ml ndc 60842-021-02 storage handling protect light . epinephrine light sensitive stored outer case . store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] . freeze . using , check make sure solution autoinjector clear colorless . replace autoinjector solution discolored , cloudy , contains particles .",
    "adverseReactions": "none .",
    "indications_original": "AUVI-Q is indicated for the emergency treatment of type I allergic reactions, including anaphylaxis, in adult and pediatric patients who weigh 7.5 kg or greater.",
    "contraindications_original": "The recommended dosage of AUVI-Q is based on weight. ( 2.1 ) Administer AUVI-Q intramuscularly or subcutaneously into the anterolateral aspect of the thigh, through clothing if necessary. ( 2.2 ) Recommended Dosage Patient\u2019s Weight Dosage 30 kg or greater AUVI-Q 0.3 mg 15 kg to less than 30 kg AUVI-Q 0.15 mg 7.5 kg to less than 15 kg AUVI-Q 0.1 mg In the absence of clinical improvement or if symptoms worsen after the initial treatment, a second dose of AUVI-Q may be administered with a second autoinjector starting 5 minutes after the first dose. ( 2.1 ) Advise patients when to seek emergency medical assistance for close monitoring of the anaphylactic episode and in the event further treatment is required. ( 2.1 ) It is recommended that patients are prescribed and have immediate access to two AUVI-Q devices at all times. ( 2.1 ) See full prescribing information for administration instructions. ( 2.2 )",
    "warningsAndPrecautions_original": "How Supplied\n                  \n                  AUVI-Q (epinephrine injection) is a clear and colorless solution for intramuscular or subcutaneous use.  AUVI-Q is available as an autoinjector as described in Table 2.\n                  \n                     Table 2. AUVI-Q Autoinjector Package Configurations and Strengths\n                  \n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                              Package Configuration\n                           \n                           \n                              Strength\n                           \n                           \n                              National Drug Code (NDC)\n                           \n                        \n                        \n                           2 autoinjectors\n                           0.3 mg/0.3 mL\n                           NDC 60842-023-02\n                        \n                        \n                           2 autoinjectors\n                           0.15 mg/0.15 mL\n                           NDC 60842-022-02\n                        \n                        \n                           2 autoinjectors\n                           0.1 mg/0.1 mL\n                           NDC 60842-021-02\n                        \n                     \n                  \n                  \n                     Storage and Handling\n                  \n                  \n                     Protect from light. Epinephrine is light sensitive and should be stored in the outer case.\n                     Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F); excursions permitted to 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [See USP Controlled Room Temperature]. Do not freeze.\n                     Before using, check to make sure the solution in the autoinjector is clear and colorless. Replace the autoinjector if the solution is discolored, cloudy, or contains particles.",
    "adverseReactions_original": "None.",
    "drug": [
        {
            "name": "Auvi-Q",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00668"
        }
    ]
}